JP2020502104A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502104A5 JP2020502104A5 JP2019531589A JP2019531589A JP2020502104A5 JP 2020502104 A5 JP2020502104 A5 JP 2020502104A5 JP 2019531589 A JP2019531589 A JP 2019531589A JP 2019531589 A JP2019531589 A JP 2019531589A JP 2020502104 A5 JP2020502104 A5 JP 2020502104A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- chain
- protein
- selenocysteine
- residues
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022184852A JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662381316P | 2016-08-30 | 2016-08-30 | |
| US62/381,316 | 2016-08-30 | ||
| US201762537986P | 2017-07-28 | 2017-07-28 | |
| US62/537,986 | 2017-07-28 | ||
| PCT/US2017/049354 WO2018045018A1 (en) | 2016-08-30 | 2017-08-30 | Production of seleno-biologics in genomically recoded organisms |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184852A Division JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020502104A JP2020502104A (ja) | 2020-01-23 |
| JP2020502104A5 true JP2020502104A5 (enExample) | 2020-10-08 |
| JP7186400B2 JP7186400B2 (ja) | 2022-12-09 |
Family
ID=61301655
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531589A Active JP7186400B2 (ja) | 2016-08-30 | 2017-08-30 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
| JP2022184852A Active JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022184852A Active JP7378106B2 (ja) | 2016-08-30 | 2022-11-18 | ゲノム的に再コードした生物におけるセレノ－生物製剤の製造 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11492650B2 (enExample) |
| EP (1) | EP3506945A4 (enExample) |
| JP (2) | JP7186400B2 (enExample) |
| CN (1) | CN109803679A (enExample) |
| CA (1) | CA3034701A1 (enExample) |
| WO (1) | WO2018045018A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9840553B2 (en) | 2014-06-28 | 2017-12-12 | Kodiak Sciences Inc. | Dual PDGF/VEGF antagonists |
| WO2017117464A1 (en) | 2015-12-30 | 2017-07-06 | Kodiak Sciences Inc. | Antibodies and conjugates thereof |
| US11542332B2 (en) | 2016-03-26 | 2023-01-03 | Bioatla, Inc. | Anti-CTLA4 antibodies, antibody fragments, their immunoconjugates and uses thereof |
| CN109844105A (zh) | 2016-07-11 | 2019-06-04 | 得克萨斯州大学系统董事会 | 包含硒代半胱氨酸的重组多肽及其产生方法 |
| BR112020017872A2 (pt) | 2018-03-02 | 2020-12-22 | Kodiak Sciences Inc. | Anticorpos de il-6 e construtos de fusão e conjugados dos mesmos |
| JP7384906B2 (ja) * | 2018-07-09 | 2023-11-21 | ジーアールオー・バイオサイエンシズ・インコーポレイテッド | 非標準アミノ酸含有組成物とその使用 |
| CN114144426A (zh) * | 2019-04-19 | 2022-03-04 | 印地安纳大学理事会 | 餐时或基础胰岛素类似物通过内部二硒桥的稳定化 |
| WO2021072265A1 (en) | 2019-10-10 | 2021-04-15 | Kodiak Sciences Inc. | Methods of treating an eye disorder |
| AU2020398327A1 (en) | 2019-12-03 | 2022-07-14 | Evotec International Gmbh | Interferon-associated antigen binding proteins and uses thereof |
| US11179473B2 (en) | 2020-02-21 | 2021-11-23 | Silverback Therapeutics, Inc. | Nectin-4 antibody conjugates and uses thereof |
| CN113512116B (zh) * | 2020-04-10 | 2022-09-20 | 苏州普乐康医药科技有限公司 | 一种抗igf-1r抗体及其应用 |
| JP2023545520A (ja) | 2020-10-14 | 2023-10-30 | ビリジアン セラピューティクス， インコーポレイテッド | 甲状腺眼疾患を治療するための組成物及び方法 |
| WO2023019171A1 (en) | 2021-08-10 | 2023-02-16 | Viridian Therapeutics, Inc. | Compositions, doses, and methods for treatment of thyroid eye disease |
| CN118076644A (zh) * | 2021-09-30 | 2024-05-24 | 正大天晴药业集团股份有限公司 | 针对免疫检查点的双特异性抗体 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6849417B1 (en) * | 1998-04-06 | 2005-02-01 | The United States Of America As Represented By The Department Of Health And Human Services | Mammalian selenoprotein differentially expressed in tumor cells |
| AU6987200A (en) | 1999-08-16 | 2001-03-13 | Karolinska Innovations Ab | Methods and means for selenoprotein expression |
| WO2007075438A2 (en) * | 2005-12-15 | 2007-07-05 | Codon Devices, Inc. | Polypeptides comprising unnatural amino acids, methods for their production and uses therefor |
| WO2009043051A2 (en) | 2007-09-27 | 2009-04-02 | Biogen Idec Ma Inc. | Cd23 binding molecules and methods of use thereof |
| KR101656107B1 (ko) * | 2007-11-20 | 2016-09-08 | 암브룩스, 인코포레이티드 | 변형된 인슐린 폴리펩티드 및 이의 용도 |
| AU2012216723B2 (en) * | 2007-11-20 | 2014-08-28 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| JP5572972B2 (ja) * | 2009-03-16 | 2014-08-20 | Ｊｎｃ株式会社 | インスリン分泌促進剤などの薬物のスクリーニング方法 |
| US20140024592A1 (en) * | 2010-09-08 | 2014-01-23 | Howard Florey Institute Of Experimental Physiology And Medicine | Modified Relaxin Polypeptides |
| MX2013008736A (es) * | 2011-01-28 | 2013-11-22 | Ca Nat Research Council | Diseño de dominios de inmunoglobulina. |
| DK2717898T3 (en) | 2011-06-10 | 2019-03-25 | Bioverativ Therapeutics Inc | COAGULATING COMPOUNDS AND PROCEDURES FOR USE THEREOF |
| US10240158B2 (en) | 2011-07-11 | 2019-03-26 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US9464288B2 (en) | 2011-07-11 | 2016-10-11 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| US10876142B2 (en) | 2011-07-11 | 2020-12-29 | Yale University | Compositions and methods for making selenocysteine containing polypeptides |
| EP2968552B1 (en) | 2013-03-14 | 2020-03-11 | The Scripps Research Institute | Targeting agent antibody conjugates and uses thereof |
| US20150050682A1 (en) | 2013-08-15 | 2015-02-19 | University Of Vermont And State Agricultural College | Direct assay of thioredoxin reductase activity |
| WO2015066543A1 (en) * | 2013-11-01 | 2015-05-07 | Board Of Regents, The University Of Texas System | Targeting her2 and her3 with bispecific antibodies in cancerous cells |
| US10118950B2 (en) | 2014-08-30 | 2018-11-06 | Northwestern University | Platforms for cell-free protein synthesis comprising extracts from genomically recoded E. coli strains having genetic knock-out mutations in release factor 1 (RF-1) and endA |
| WO2016172269A2 (en) * | 2015-04-20 | 2016-10-27 | University Of Utah Research Foundation | Insulin analogs having shortened b chain peptides and associated methods |
| CN105111304B (zh) * | 2015-09-30 | 2018-12-14 | 山东阿华生物药业有限公司 | 重组人胰岛素前体的纯化和酶切转换方法 |
| US10557160B2 (en) | 2015-12-15 | 2020-02-11 | Board Of Regents, The University Of Texas System | Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same |
| CN109844105A (zh) * | 2016-07-11 | 2019-06-04 | 得克萨斯州大学系统董事会 | 包含硒代半胱氨酸的重组多肽及其产生方法 |
| AU2017298565B2 (en) | 2016-07-22 | 2021-08-19 | The Walter And Eliza Hall Institute Of Medical Research | Insulin analogs |
| IL264330B2 (en) * | 2016-07-22 | 2024-05-01 | Univ Utah Res Found | An insulin analog, pharmaceutical composition comprising it and its uses |
| CN114144426A (zh) | 2019-04-19 | 2022-03-04 | 印地安纳大学理事会 | 餐时或基础胰岛素类似物通过内部二硒桥的稳定化 |
-
2017
- 2017-08-30 CA CA3034701A patent/CA3034701A1/en active Pending
- 2017-08-30 US US16/329,761 patent/US11492650B2/en active Active
- 2017-08-30 CN CN201780053385.XA patent/CN109803679A/zh active Pending
- 2017-08-30 JP JP2019531589A patent/JP7186400B2/ja active Active
- 2017-08-30 WO PCT/US2017/049354 patent/WO2018045018A1/en not_active Ceased
- 2017-08-30 EP EP17847457.3A patent/EP3506945A4/en active Pending
-
2022
- 2022-11-18 JP JP2022184852A patent/JP7378106B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502104A5 (enExample) | ||
| CO2020001113A2 (es) | Muteínas de interleucina 21 y métodos de tratamiento | |
| JP2020503891A5 (enExample) | ||
| JP2016505635A5 (enExample) | ||
| JP2014000092A5 (enExample) | ||
| PH12020551019A1 (en) | IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
| AR095432A1 (es) | Proteínas de unión a antígeno | |
| AR075504A1 (es) | Moleculas de anticuerpos que tienen especificidad para el ox40 humano | |
| JP2015525217A5 (enExample) | ||
| FI3436048T3 (fi) | Neoantigeeneja ja niiden käyttömenetelmiä | |
| JP2015212284A5 (enExample) | ||
| JP2017538401A5 (enExample) | ||
| AR075047A1 (es) | Metodos y composiciones en base a la proteina tipo 2 de la toxina shiga. polipeptido purificado. anticuerpo ant-stx2. kit. | |
| UA107330C2 (uk) | Туберкульозний білок rv3616c та його застосування | |
| EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
| PE20161221A1 (es) | Anticuerpos de il-21 | |
| FI3452507T3 (fi) | Tau-immuunihoito | |
| CN113366016A (zh) | 抗人白细胞介素5(il-5)单克隆抗体及其应用 | |
| JP2015521206A5 (enExample) | ||
| AR099068A1 (es) | Anticuerpo anti-netrina-1 | |
| EP3932418A3 (en) | Peptides for use in promoting transport of glucose | |
| JP2014504297A5 (enExample) | ||
| PE20191662A1 (es) | Anticuerpos anti-il-5 | |
| JP2012516140A5 (enExample) | ||
| Ó Gaora et al. | Mycobacteria as immunogens: development of expression vectors for use in multiple mycobacterial species |